期刊文献+

miR-224、miR-135a在非小细胞肺癌中的表达及与临床病理的关系 被引量:6

Expression of miR-224 and miR-135a in non-small cell lung cancer and the relation with clinical pathology
下载PDF
导出
摘要 目的:检测miR-224与miR-135a两种microRNA(miRNA)在非小细胞肺癌中的表达,探讨其与肺癌临床病理的关系。方法:采用Real time RT-PCR法对31例非小细胞肺癌组织及癌旁正常肺组织的miR-224与miR-135a进行定量分析,结果由2(-△△CT)处理,并分析与临床病理资料的关系。结果:相对内参U6,miR-224在非小细胞肺癌组织中表达量为4.2761±0.8731,在正常肺组织中的表达量为0.8967±0.2154,两者相比P<0.05,miR-135a在非小细胞肺癌组织中表达量为0.3551±0.0985,在正常肺组织中的表达量为1.7443±0.3125,两者相比P<0.05。miR-224与miR-135a的表达与非小细胞肺癌的临床分期、病理分级密切相关。结论:miR-224高表达及miR-135a低表达与非小细胞肺癌的临床分期、病理分级密切相关,miR-224有可能作为非小细胞肺癌的重要肿瘤标志物。 Objective:To detect the expression of miR-224 and miR-135a in nonsmall cell lung cancer,discuss their relationships with the clinical pathology of lung cancer.Methods: 2(-△△CT) method was used for quantitative analysis of the expression of miR-224 and miR-135a in 31 nonsmall cell lung cancer tissue and adjacent normal tissue by real time RT-PCR,and analysis ze relationship with clinical pathology information.Results: Comparative with internal reference U6,the expression of miR-224 in nonsmall cell lung cancer tissue was 4.2761±0.8731,while 0.8967±0.2154 in normal lung tissue(P0.05).The expression of miR-135a in nonsmall cell lung cancer C tissue was 0.3551±0.0985,while 1.7443±0.3125 in normal lung tissue(P0.05).The expression of miR-224 and miR-135a WAS highly related with clinical stage,pathology grade of nonsmall cell lung cancer.Conclusion: The high level expression of miR-224 and the low level expression of miR-135a are highly related with clinical stage,pathology grade of nonsmall cell lung cancer,miR-224 might be the significant tumor marker of nonsmall cell lung cancer.
出处 《现代肿瘤医学》 CAS 2012年第10期2057-2059,共3页 Journal of Modern Oncology
关键词 miR-224 miR-135a 非小细胞肺癌 REAL TIME RT-PCR miR-224 miR-135a non small cell lung cancer real time RT-PCR
  • 相关文献

参考文献18

  • 1Sekido Y,Fong KM, Minna JD. Molecular genetics of lung cancer [ J ]. Annu Rev Med,2003,54 ( 1 ) :73 - 87.
  • 2Minna JD,Roth JA, Gazdar AF. Focus on lung cancer[ J]. Cancer Ce11,2002,1 (1) :49 -52.
  • 3Zhang Y,Li M,Wang H,et al. Profiling of 95 microRNAs in pan- creatic cancer cell lines and surgical specimens by real - time PCR analysis[J]. World J Surg,2009,33 (4) : 698.
  • 4Oulas A, Reczko M, Poirazi P. MieroRNAs and cancer - the search begins[ J]. IEEE Trans Inf Technol Biomed,2009,13 ( 1 ) : 67 - 77.
  • 5Kim VN, Nam JW. Genomies of microRNA [J]. Trends Genet, 2006,22(3) : 165 - 173.
  • 6Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis [ J ]. Br J Cancer, 2006 ( 6 ) , 94 : 776 - 780.
  • 7Bartel DP. MieroRNAs : genomics, biogenesis, mechanism, and function[ J ]. Cell ,2004,116 (2) :281 - 297.
  • 8Corney DC, Flesken - Nikitin A, Godwin AK, et al. MicroRNA -34b and microRNA - 34c are targets of p53 and cooperate in con- trol of cell proliferation and adhesion - independent growth[J].Cancer Res ,2007,67 ( 8 ) :8433 - 8438.
  • 9Cimmino A,Calin GA,Fabbri M,et al. MiR - 15 and miR - 16 in- duce apoptosis by targeting BCL2 [ J]. Proc Natl Acad Sci USA, 2005,102 ( 39 ) : 13944 - 13949.
  • 10Johnson SM, Grosshans H,Shingara J, et al. RAS is regulated by the let -7 microRNA family[J]. Ce11,2005,120(5) :635 -647.

同被引文献53

  • 1t Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer [J] . J Pathol, 2011, 223 (2) : 102- 115.
  • 2Xie B, Ding Q, Han H, et al. miRCancer: a microRNA - cancer association database constructed by text mining on liter- ature [J] . Bioinformaties, 2013, 29 (5): 638-644.
  • 3Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomark- er studies [ J] .Cancer Prey Res, 2012, 5 (3): 492 - 497.
  • 4Brennecke J,Hipfner DR,Stark A,et al.Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in dro-sophila[J].Cell,2003,113(1):25-36.
  • 5Li Q,Wang G,Shan JL,et al.MicroRNA-224 is unregulated in HepG2 cells and involved in cellular migration and inva-sion[J].J Gastroenterol Hepatol,2010,25(1):164-171.
  • 6Boguslawska J,Wojcicka A,Piekielko-Witkowska A,et al.MiR-224 targets the 3 UTR of type I 5^iodothyronine deio-dinase possibly contributing to tissue hypothyroidism in renal cancer[J].PLoS One,2011,6(9);e24541.
  • 7White NM,Chow TF,Mejia-Guerrero S,et al.Three dysreg-ulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer[J].Br J Cancer,2010,102(8):1244-1253.
  • 8Prueitt RL,Yi M,Hudson RS,et al.Expression of microR-NAs and protein-coding genes associated with perineural invasion in prostate cancer[J].Prostate,2008,68(11):1152-1164.
  • 9Wotschofsky Z,Busch J,Jung M,et al.Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy[J].Clin Chim Acta,2013,416(1):5-10.
  • 10Wang Y,Lee AT,Ma JZ,et al.Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target[J].J Biol Chem,2008,283(19):13205-13215.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部